Last reviewed · How we verify

NCT06651879

Ultrasound Airway Assessment of Critically Ill Preeclamptic; Comparison Between Two Technique

Recruiting now NA Last updated 18 February 2025
What this trial tests

NA trial testing techniques of ultrasound examination of the airway in Critical Illness in 50 participants. Currently enrolling.

Timeline
20 July 2024
Primary endpoint
20 November 2025
1 December 2025

Quick facts

Lead sponsorAin Shams University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposediagnostic
Enrollment50
Start date20 July 2024
Primary completion20 November 2025
Estimated completion1 December 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Eligibility, female only, with Critical Illness or Difficult; Intubation, Postpartum, During Puerperium. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Unexpected difficult airway exposes the patient to serious morbidity and even mortality. The changes in pregnancy and preeclampsia increase the risk of difficult intubation. Proper anticipation affects the outcome and enhances safety, especially in critically ill patients. This research aims to assess the superiority of either 2 views or 5 views ultrasound assessment in predictivity of difficult airway (difficult ventilation, laryngoscopy, and intubation) and their comparison to traditional clinical examination by El-Ganzouri Risk Index (EGRI) in critically ill obstetric patients with pre-eclampsia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Critical Illness

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06651879.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing